FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR

When it comes to intermediate coronary lesion revascularization decision making, functional assessment is the recommended. At present, several indices are used, such as fractional flow reserve (FFR) and non-hyperemic coronary flow ratios. Among these, angiography based quantitative flow ratio (QFR), allows FFR estimation. Numerous studies have validated the use of QFR for coronary lesion revascularization decision making. 

However, the FAVOR III Europa randomized trial, published ad hoc, showed that QFR guided strategies do not reach non-inferiority vs FFR as regards major adverse cardiac events (MACE).

Even though revascularization deferral strategies based on physiological parameters have been shown safe for conventional indices, QFR safety has not yet been clearly established. 

Coronary Revascularization Strategies: QFR vs FFR in Intermediate Lesions

The aim of this Favor III Europa (randomized and multicenter) sub-analysis was to assess the safety of deferred revascularization based on QFR vs FFR. 

Read also: TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions.

Primary end point was one-year MACE rate, defined as all-cause death, acute MI, or unplanned coronary revascularization. Secondary end point included individual primary end point components and target vessel failure (TVF).

The FAVOR III Europa trial included 2,000 patients, 1,008 assigned to QFR and 992 to FFR. Mean patient age was 66 and they were mostly men. The most frequent clinical presentation was chronic coronary syndrome.  

A total of 523 QFR patients (55.2%) and 599 FFR patients (65.3%) had at least one deferred revascularization. 433 of these QFR patients (82.8%) and 511 (85.3%) FFR patients had complete deferred revascularization of all lesions. In this subgroup, MACE rate was significantly higher among QFR patients vs FFR (24 [5.6%] vs 14 [2.8%]; HR 2.07; CI 95%: 1.07–4.03; p = 0.03). 

Read also: ROUTE TRAIL: DKCRUSH vs. DKRUSH Culotte in Non-Left Main Bifurcation Lesions.

In the subgroup of patients with at least one deferred lesion, MACE rate was 5.6% vs 3.6%, respectively (HR 1.55; CI  95%: 0.88–2.73; p = 0.13).

Conclusion: Impact of QFR vs FFR on Major Adverse Cardiac Events 

In this sub-analysis, QFR based deferred coronary revascularization was associated with higher MACE rate vs FFR. This difference was mainly related to an increase in unplanned revascularization. 

Original Title: Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial.

Reference: Birgitte K. Andersen MD et al EuroIntervention 2025;21:e1-e10.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...